Total words: 4696 | 2-word phrases: 1209 | 3-word phrases: 1424 | 4-word phrases: 1510
Title | Try to keep the title under 60 characters (65 characters) Hematocrit Control & Spleen Reduction in PV Patients | Jakafi |
Description | Try to keep the meta description between 50 - 160 characters (174 characters) Learn how Jakafi® (ruxolitinib) may help to control Hematocrit and reduce Spleen size in adults with Polycythemia Vera(PV), who didn't respond to Hydroxyurea treatment. |
Keywords | Meta keywords are not recommended anymore (0 characters) |
H1 | No H1 tag on the page (0 characters) |
# | Keyword | H1 | Title | Des | Volume | Position | Suggest | Frequency | Density |
---|---|---|---|---|---|---|---|---|---|
1 | or | 56 | 10.13% | ||||||
2 | and | 51 | 9.22% | ||||||
3 | of | 46 | 8.32% | ||||||
4 | to | 42 | 7.59% | ||||||
5 | jakafi | 41 | 7.41% | ||||||
6 | your | 39 | 7.05% | ||||||
7 | with | 35 | 6.33% | ||||||
8 | you | 30 | 5.42% | ||||||
9 | the | 28 | 5.06% | ||||||
10 | not | 28 | 5.06% |
# | URL | Whois | Check |
---|---|---|---|
1 | https://www.jakafi.com/jakafi-prescribing-information | Whois | jakafi.com |
2 | https://www.jakafi.com/ | Whois | jakafi.com |
3 | https://www.incytecares.com/ | Whois | incytecares.com |
4 | https://www.jakafi.com/ | Whois | jakafi.com |
5 | https://www.jakafi.com/polycythemia-vera/pv-medication-hydroxyurea-intolerant | Whois | jakafi.com |
6 | https://www.jakafi.com/jakafi-prescribing-information | Whois | jakafi.com |
7 | https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program | Whois | fda.gov |
8 | https://incyte.com/ | Whois | incyte.com |
9 | https://incyte.com/privacy-policy | Whois | incyte.com |
10 | https://incyte.com/legal-notice | Whois | incyte.com |
11 | https://incyte.com/consumer-health-data-privacy-policy | Whois | incyte.com |
12 | https://incyte.com/cookies | Whois | incyte.com |
13 | https://www.jakafi.com/contact-us | Whois | jakafi.com |
14 | https://incyte.com/privacy-policy | Whois | incyte.com |
15 | https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program | Whois | fda.gov |